Konstantin Linnik, Nutter McClennen & Fish LLP Photo

Konstantin M. Linnik

Partner / Boston


Konstantin Linnik is a partner in Nutter’s Intellectual Property Department. He works with biotechnology and pharmaceutical companies on various matters involving intellectual property, such as IP strategy, building and leveraging patent portfolios, competitive analysis, product design and development, licensing and negotiations, due diligence and IP audits, and patent enforcement and litigation.

Read More

Before joining Nutter, Konstantin was Senior Corporate Counsel at Pfizer, where he was lead patent counsel for Pfizer research units located in Cambridge, Massachusetts; Düsseldorf, Germany; and Ottawa, Canada. Prior to Pfizer, he had worked at two leading law firms representing numerous pharma and biotech companies as their external counsel.

Active in the Boston legal community and industry organizations, Konstantin currently chairs the Patent Law Committee of the Boston Patent Law Association and serves as co-chair of the Massachusetts Biotechnology Council’s Legal & Regulatory committee. In addition, he serves on the board of directors of Seeding Labs, a non-profit organization that provides lab equipment and resources to scientists in the developing world. Konstantin is also an adjunct professor at Suffolk University Law School where he teaches IP licensing.

Representative Experience 

  • Prosecuted 1,300+ biotechnology/pharma patent applications in the US and abroad, including world-wide portfolios for mid-size and large pharmaceutical/biotech clients and start-ups 
  • Broad-range IP support for R&D programs and platform technologies (antisense, siRNA, drug formulations, immune modulators, stem cells, etc.) across therapeutic areas (e.g., diabetes, heart disease, cancer, ophthalmology, vaccines), development phases and support lines (drug safety and metabolism, formulation, regulatory, business development (BD), transactional, corporate VC) 
  • Drafted, negotiated, or amended numerous IP related agreements, including in-/out-licensing, acquisitions, technology evaluations, and corporate VC investments 
  • Managed a patent portfolio of 1,000+ cases ($3M+ budget), prosecuted by multiple outside counsel, portfolio audits and quality reviews 
  • Handled ANDA disputes, inventorship disputes, interferences, re-exams and European oppositions 
  • Performed multiple large-scale landscape studies, freedom-to-operate and validity analyses, multiple IP due diligence investigations in various transactions including licensing-in, -out, IPO’s and acquisitions
  • Drafted over 70 original patent applications on a wide range of technologies, including: gene therapy, stem cells, DNA sequencing and analysis, PCR, immunology, antibodies, protein biochemistry, new genes, vectors, treatment regimens, purification techniques, surgical methods, small molecule therapeutics, research tools and bioinformatics

To view Konstantin's LinkedIn profile, please click here.

News & Insights


Speaking Engagements


Blog Posts



  • Massachusetts Super Lawyers Rising Stars, 2013-2014

Education & Admissions


Suffolk University Law School, J.D., cum laude

Boston University School of Medicine, Ph.D., Biophysics/Cell Biology

Moscow Institute of Physics and Technology, B.S., Physical & Chemical Biology


  • Massachusetts
  • U.S. Patent and Trademark Office
  • U.S. District Court for the District of Massachusetts
  • District of Columbia
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Supreme Court

Notable Experience

Konstantin has prosecuted 1,300+ biotechnology/pharma patent applications in the US and abroad, including world-wide portfolios for mid-size and large pharmaceutical/biotech clients and start-ups.


Massachusetts Super Lawyers Rising Stars, 2013-2014